WO2007057182A3 - Fluoreszenz-nanopartikel - Google Patents

Fluoreszenz-nanopartikel Download PDF

Info

Publication number
WO2007057182A3
WO2007057182A3 PCT/EP2006/010996 EP2006010996W WO2007057182A3 WO 2007057182 A3 WO2007057182 A3 WO 2007057182A3 EP 2006010996 W EP2006010996 W EP 2006010996W WO 2007057182 A3 WO2007057182 A3 WO 2007057182A3
Authority
WO
WIPO (PCT)
Prior art keywords
fluorescent nanoparticles
passivation layer
inorganic core
nanoparticles
emission
Prior art date
Application number
PCT/EP2006/010996
Other languages
English (en)
French (fr)
Other versions
WO2007057182A2 (de
WO2007057182B1 (de
Inventor
Sven Laarmann
Kathrin Zeller
Karin Mittmann
Christoph Block
Claudia Arntz
Original Assignee
Signalomics Gmbh
Sven Laarmann
Kathrin Zeller
Karin Mittmann
Christoph Block
Claudia Arntz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05025022.4A external-priority patent/EP1787659B1/de
Priority to EP10011333A priority Critical patent/EP2308513A3/de
Priority to EP05025022.4A priority patent/EP1787659B1/de
Priority to CA2628678A priority patent/CA2628678C/en
Priority to CN200680049170.2A priority patent/CN101360515B/zh
Priority to AU2006314773A priority patent/AU2006314773B2/en
Application filed by Signalomics Gmbh, Sven Laarmann, Kathrin Zeller, Karin Mittmann, Christoph Block, Claudia Arntz filed Critical Signalomics Gmbh
Priority to US12/093,977 priority patent/US8974767B2/en
Priority to JP2008540516A priority patent/JP5537808B2/ja
Publication of WO2007057182A2 publication Critical patent/WO2007057182A2/de
Publication of WO2007057182A3 publication Critical patent/WO2007057182A3/de
Publication of WO2007057182B1 publication Critical patent/WO2007057182B1/de
Priority to HK09107061.0A priority patent/HK1129567A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/62—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing gallium, indium or thallium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/54—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing zinc or cadmium
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/56—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing sulfur
    • C09K11/562—Chalcogenides
    • C09K11/565—Chalcogenides with zinc cadmium
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/74—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing arsenic, antimony or bismuth
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • C09K11/74—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing arsenic, antimony or bismuth
    • C09K11/7442—Aluminates; Silicates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Luminescent Compositions (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Endoscopes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Verwendung fluoreszierender Nanopartikel enthaltend einen anorganischen Kern, eine Passivierungsschicht und spezifische Liganden mit einem hydrodynamischen Durchmesser des anorganischen Kerns mit der Passivierungsschicht von nicht mehr als 15 nm, vorzugsweise von nicht mehr als 10 nm, besonders bevorzugt von nicht mehr als 5 nm zur Herstellung eines in vivo Diagnostikums, wobei die Nanopartikel eine Emission von weniger als 700 nm aufweisen.
PCT/EP2006/010996 2005-11-16 2006-11-16 Fluoreszenz-nanopartikel WO2007057182A2 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP10011333A EP2308513A3 (de) 2005-11-16 2005-11-16 Fluoreszenz-Nanopartikel
EP05025022.4A EP1787659B1 (de) 2005-11-16 2005-11-16 Fluoreszenz-Nanopartikel
JP2008540516A JP5537808B2 (ja) 2005-11-16 2006-11-16 蛍光ナノ粒子
CN200680049170.2A CN101360515B (zh) 2005-11-16 2006-11-16 荧光纳米微粒
AU2006314773A AU2006314773B2 (en) 2005-11-16 2006-11-16 Fluorescent nanoparticles
CA2628678A CA2628678C (en) 2005-11-16 2006-11-16 Fluorescent nanoparticles
US12/093,977 US8974767B2 (en) 2005-11-16 2006-11-16 Fluorescent nanoparticles
HK09107061.0A HK1129567A1 (en) 2005-11-16 2009-08-03 Fluorescent nanoparticles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05025022.4 2005-11-16
EP05025022.4A EP1787659B1 (de) 2005-11-16 2005-11-16 Fluoreszenz-Nanopartikel

Publications (3)

Publication Number Publication Date
WO2007057182A2 WO2007057182A2 (de) 2007-05-24
WO2007057182A3 true WO2007057182A3 (de) 2008-02-28
WO2007057182B1 WO2007057182B1 (de) 2008-04-17

Family

ID=37752631

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/010996 WO2007057182A2 (de) 2005-11-16 2006-11-16 Fluoreszenz-nanopartikel

Country Status (9)

Country Link
US (1) US8974767B2 (de)
JP (2) JP5537808B2 (de)
KR (1) KR20080070746A (de)
CN (1) CN101360515B (de)
AU (1) AU2006314773B2 (de)
CA (1) CA2628678C (de)
ES (1) ES2627998T3 (de)
HK (1) HK1129567A1 (de)
WO (1) WO2007057182A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101977925B (zh) 2008-02-29 2014-11-05 西格纳洛米克斯有限公司 优化的粘附素片段及相应的纳米颗粒
WO2010016803A1 (en) * 2008-08-05 2010-02-11 Agency For Science, Technology And Research Methods, compositions, and articles comprising stabilized gold nanoclusters
KR101032307B1 (ko) * 2008-10-02 2011-05-06 전북대학교병원 생체적합성 분자광학영상용 양자점 및 이의 제조방법
US20100317966A1 (en) * 2009-06-05 2010-12-16 Institut National D'optique Hybrid-multimodal magneto-optical contrast markers
CN102869749B (zh) * 2010-04-30 2013-11-13 海洋王照明科技股份有限公司 一种硼酸盐基红色发光材料及其制备方法
CN102366632A (zh) * 2011-08-22 2012-03-07 长春工业大学 顺磁性金属配合物功能化的荧光金纳米簇磁共振和荧光成像造影剂
WO2013123390A1 (en) * 2012-02-16 2013-08-22 Qd Vision, Inc. Method for preparing semiconductor nanocrystals
DE102013206077A1 (de) 2013-04-05 2014-10-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Blau-emittierende Leuchtdioden auf Basis von Zinkselenid-Quantenpunkten
ES2639855T3 (es) 2013-12-23 2017-10-30 Exchange Imaging Technologies Gmbh Nanopartícula conjugada a péptidos de unión a CD44
EP3028721A1 (de) * 2014-12-05 2016-06-08 Exchange Imaging Technologies GmbH Nanopartikel-Formulierung mit umgekehrter thermischer Gelierung zur Injektion
JP6683571B2 (ja) * 2016-08-10 2020-04-22 トヨタ自動車株式会社 排ガス浄化触媒
EP3522926A1 (de) * 2016-10-04 2019-08-14 Nanoco Technologies Ltd Polymerisierbare quantenpunktnanopartikel und deren verwendung als therapie-, ablations- und tätowiermittel
WO2018135434A1 (ja) * 2017-01-18 2018-07-26 三菱マテリアル株式会社 可視蛍光を発するＣｄを含まないコロイダル量子ドット及びその製造方法
JP2018115315A (ja) * 2017-01-18 2018-07-26 三菱マテリアル株式会社 可視蛍光を発するＣｄを含まないコロイダル量子ドット及びその製造方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040247861A1 (en) * 2001-09-17 2004-12-09 Imad Naasani Functionalized fluorescent nanocrystal compositions and methods of making
WO2005001889A2 (en) * 2003-05-07 2005-01-06 Indiana University Research & Technology Corporation Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto
US20050112376A1 (en) * 2001-09-17 2005-05-26 Imad Naasani Nanocrystals
WO2005081721A2 (en) * 2003-12-12 2005-09-09 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048846A1 (en) * 1997-04-29 1998-11-05 Nycomed Imaging As Light imaging contrast agents
US6207392B1 (en) * 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6306610B1 (en) * 1998-09-18 2001-10-23 Massachusetts Institute Of Technology Biological applications of quantum dots
US6179912B1 (en) * 1999-12-20 2001-01-30 Biocrystal Ltd. Continuous flow process for production of semiconductor nanocrystals
US6748259B1 (en) * 2000-06-15 2004-06-08 Spectros Corporation Optical imaging of induced signals in vivo under ambient light conditions
US20020127224A1 (en) * 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy
US8088358B2 (en) * 2001-03-08 2012-01-03 Centrum Fur Angewandte Nanotechnologie (Can) Gmbh Paramagnetic nanoparticle
CA2474386C (en) 2002-01-24 2011-07-05 Barnes-Jewish Hospital Integrin targeted imaging agents
CN1672052A (zh) * 2002-06-27 2005-09-21 佐治亚技术研究公司 纳米级光学荧光标记及其用途
US7939170B2 (en) * 2002-08-15 2011-05-10 The Rockefeller University Water soluble metal and semiconductor nanoparticle complexes
US20040101822A1 (en) * 2002-11-26 2004-05-27 Ulrich Wiesner Fluorescent silica-based nanoparticles
AU2003285133A1 (en) 2003-11-05 2005-06-24 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Biofunctionalized quantum dots for biological imaging
JP2005226021A (ja) * 2004-02-16 2005-08-25 Nihon Medi Physics Co Ltd マンノース受容体親和性化合物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040247861A1 (en) * 2001-09-17 2004-12-09 Imad Naasani Functionalized fluorescent nanocrystal compositions and methods of making
US20050112376A1 (en) * 2001-09-17 2005-05-26 Imad Naasani Nanocrystals
WO2005001889A2 (en) * 2003-05-07 2005-01-06 Indiana University Research & Technology Corporation Alloyed semiconductor quantum dots and concentration-gradient alloyed quantum dots, series comprising the same and methods related thereto
WO2005081721A2 (en) * 2003-12-12 2005-09-09 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes

Also Published As

Publication number Publication date
WO2007057182A2 (de) 2007-05-24
HK1129567A1 (en) 2009-12-04
KR20080070746A (ko) 2008-07-30
ES2627998T3 (es) 2017-08-01
AU2006314773A1 (en) 2007-05-24
JP2013079962A (ja) 2013-05-02
US8974767B2 (en) 2015-03-10
JP5537808B2 (ja) 2014-07-02
CA2628678A1 (en) 2007-05-24
CA2628678C (en) 2016-01-05
US20090226371A1 (en) 2009-09-10
CN101360515A (zh) 2009-02-04
AU2006314773B2 (en) 2013-04-11
JP2009516182A (ja) 2009-04-16
CN101360515B (zh) 2014-03-19
WO2007057182B1 (de) 2008-04-17

Similar Documents

Publication Publication Date Title
WO2007057182A3 (de) Fluoreszenz-nanopartikel
WO2006068653A3 (en) Nanoparticles with inorganic core and methods of using them
WO2007095454A3 (en) Carbon-encased metal nanoparticles and sponges, methods of synthesis, and methods of use
WO2004071341A3 (en) Disposable absorbent article comprising a durable hydrophilic core wrap
WO2008014464A3 (en) Polymeric core-shell nanoparticles with interphase region
WO2009136974A3 (en) Thick-shell nanocrystal quantum dots
EP1930100A3 (de) Verbundkernform, Herstellungsverfahren dafür und damit hergestellte Gegenstände
MX2010001500A (es) Dioxido de titanio fotoactivo en materiales de revestimiento.
TW200611959A (en) Coated water soluble nanoparticles
WO2006017333A3 (en) Shortened carbon nanotubes
EP1731550A4 (de) Neues wasserlösliches fulleren, herstellungsverfahren dafür und aktivsauerstoffgenerator mit dem fulleren
EP2017318A3 (de) Zubereitung für eine wässrige Dispersion zum chemisch-mechanischen Polieren, Verfahren zur Herstellung einer wässrigen Dispersion zum chemisch-mechanischen Polieren, wässrige Dispersion zum chemisch-mechanischen Polieren und Verfahren zum chemisch-mechanischen Polieren
WO2004108902A3 (en) Biocompatible fluorescent silicon nanoparticles
JP2006523762A5 (de)
WO2007115305A3 (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor
WO2008073171A3 (en) Monodisperse single-walled carbon nanotube populations and related methods for providing same
EP1615241A3 (de) Band aus amorpher Eisenbasislegierung
TW200641068A (en) Luminant pigment aqueous media dispersing liquid and luminant paint
JP2007508854A5 (de)
WO2007079290A8 (en) Flushable body collection pouches, pouch- in- pouch appliances using the same, and methods of making the same
WO2008007290A3 (en) Core-shell nanoparticles for thearapy and imaging purposes
IL179143A0 (en) New water-soluble form of coenzyme q10 in the form of an inclusion complex with beta-cyclodextrin, process of preparing, and use thereof
WO2005095524A3 (en) Method of delaminating aggregated particles with a coating agent in a substantially supercritical fluid
WO2009129649A8 (en) Biocompatible polymer and magnetic nanoparticle with biocompatibility
EP1683979A3 (de) Verfahren zur Herstellung einer kombinierten Rohr- und Gabel-Anordnung einer Antriebswelle

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680049170.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2628678

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2006314773

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2008540516

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2427/CHENP/2008

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2006314773

Country of ref document: AU

Date of ref document: 20061116

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2006314773

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020087014538

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 12093977

Country of ref document: US

122 Ep: pct application non-entry in european phase

Ref document number: 06818584

Country of ref document: EP

Kind code of ref document: A2